Côte d'Ivoire vs Sur: Previously treated cases tested for RR-/MDR-TB
Côte d'Ivoire
100.0%
in 2024
Sur
62.0%
in 2024
Côte d'Ivoire rank
1st
Sur rank
2nd
Previously treated cases tested for RR-/MDR-TB over time
- Côte d'Ivoire
- Sur
How they compare
Côte d'Ivoire currently reports 100.0% against 62.0% in Sur, a difference of 38.0%.
That makes Côte d'Ivoire's figure about 1.6 times Sur's.
The two have swapped places 5 times across 16 shared years of data; in 2005 it was Sur ahead.
Côte d'Ivoire ranks 1st and Sur ranks 2nd of 180 countries.
Across the 3 decades both report, Côte d'Ivoire averaged higher in 2 and Sur in 1.
Head to head by decade
| Decade | Côte d'Ivoire | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 8.6% | 14.3% | 5.8% | Sur |
| 2010s | 67.2% | 54.6% | 12.6% | Côte d'Ivoire |
| 2020s | 98.4% | 78.4% | 20.0% | Côte d'Ivoire |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Côte d'Ivoire or Sur?
- Côte d'Ivoire, at 100.0% against 62.0% in Sur as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Côte d'Ivoire and Sur?
- 38.0%, with Côte d'Ivoire ahead.
- How many years of comparable data are there for Côte d'Ivoire and Sur?
- 16 years are reported by both, from 2005 to 2024.
- How do Côte d'Ivoire and Sur rank globally for previously treated cases tested for rr-/mdr-tb?
- Côte d'Ivoire ranks 1st and Sur ranks 2nd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.